Serum neurofilament light-chain levels in MS are regarded as a marker of neuron–axonal injury and correlate modestly with radiological lesion volume (only in individuals with gadolinium-enhancing lesions) and subsequent loss of brain and spinal cord volume [45,46,47,48]. The gene discussed is NEFL; the disease is myeloid sarcoma.